risedronic acid has been researched along with Bone Stress Reaction in 6 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One of the patients was treated with alendronate therapy in concern of her risk factors for osteoporosis (her previous a hysterectomy with bilateral oophorectomy) with unsubstantiated evidence of her pretreatment, bone-mineral-density measurements (BMD), for a 10-year prior episode of left prodromal thigh pain and an insufficiency fracture at 8 days post experiencing the pain." | 3.77 | Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases. ( Angthong, C; Angthong, W, 2011) |
| " We conclude that prophylactic treatment with risedronate in a training population at high risk for stress fracture using a maintenance dosage for the treatment of osteoporosis does not lower stress fracture risk." | 2.71 | The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits. ( Burr, D; Finestone, A; Goldich, Y; Kaufman, S; Kreiss, Y; Liebergall, M; Milgrom, C; Novack, V; Pereg, D; Zimlichman, E, 2004) |
| "After the pain is resolved and the examination shows improvement, patients may gradually increase their level of activity." | 2.47 | Stress fractures: diagnosis, treatment, and prevention. ( Kapil, N; Patel, DS; Roth, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aspenberg, P | 1 |
| Schilcher, J | 1 |
| Fahlgren, A | 1 |
| Kidd, LJ | 1 |
| Cowling, NR | 1 |
| Wu, AC | 1 |
| Kelly, WL | 1 |
| Forwood, MR | 1 |
| Patel, DS | 1 |
| Roth, M | 1 |
| Kapil, N | 1 |
| Angthong, C | 1 |
| Angthong, W | 1 |
| Milgrom, C | 1 |
| Finestone, A | 1 |
| Novack, V | 1 |
| Pereg, D | 1 |
| Goldich, Y | 1 |
| Kreiss, Y | 1 |
| Zimlichman, E | 1 |
| Kaufman, S | 1 |
| Liebergall, M | 1 |
| Burr, D | 1 |
| Shiraki, M | 1 |
2 reviews available for risedronic acid and Bone Stress Reaction
| Article | Year |
|---|---|
Stress fractures: diagnosis, treatment, and prevention.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Calcium, Diet | 2011 |
[Risedronate: clinical usage].
Topics: Bone Density; Clinical Trials as Topic; Etidronic Acid; Femoral Neck Fractures; Fractures, Stress; H | 2002 |
1 trial available for risedronic acid and Bone Stress Reaction
| Article | Year |
|---|---|
The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits.
Topics: Etidronic Acid; Fractures, Stress; Humans; Incidence; Israel; Male; Military Personnel; Risedronic A | 2004 |
3 other studies available for risedronic acid and Bone Stress Reaction
| Article | Year |
|---|---|
Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.
Topics: Alendronate; Bone Density Conservation Agents; Bone Nails; Bone Resorption; Etidronic Acid; Female; | 2010 |
Bisphosphonate treatment delays stress fracture remodeling in the rat ulna.
Topics: Animals; Bone Density Conservation Agents; Bone Remodeling; Bony Callus; Diaphyses; Diphosphonates; | 2011 |
Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Drug Administration Schedule; Etidronic Acid; F | 2011 |